Preparation of purified sorbed botulinum toxoid type F. 3. Purification, concentration and detoxification of toxin
Tsarapkin, V.P.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(1): 71-74
1972
ISSN/ISBN: 0372-9311 PMID: 5010284 Document Number: 55847
Document emailed within 1 workday
Related Documents
Tsarapkin, V.P. 1971: Preparation of purified sorbed botulinum toxoid type F. II. Activity of crude toxins and toxoids Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(11): 105-108Iwashige, H.; Nemeto, Y.; Takahashi, H.; Maruo, T. 1995: Botulinum toxin type a purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force Japanese Journal of Ophthalmology 39(4): 424-431
Anosov, I.I.; Bulatova, T.I. 1983: Morphological and histochemical reactions of an organism to the administration of Clostridium botulinum toxin. IX. Reactions of the neurons of the abducens nerve nucleus and of the Darkshevich's nucleus to the administration of C. botulinum type B toxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 101-105
Baschenko, I.A.; Khavkin, I.A. 1986: The use of highly purified staphylococcal alpha-toxin in the immunochemical purification of antibodies Voprosy Meditsinskoi Khimii 32(4): 27-32
Al-Ahmad, H.T.; Al-Qudah, M.A. 2006: The treatment of masseter hypertrophy with botulinum toxin type A Saudi Medical Journal 27(3): 397-400
Belin, E.E.; Polo, J. 2003: Treatment of compensatory hyperhidrosis with botulinum toxin type a Cutis 71(1): 68-70
Comella, C.L.; Jankovic, J.; Brin, M.F. 2000: Use of botulinum toxin type a in the treatment of cervical dystonia Neurology 55(12 Suppl 5: S15-S21
Luick, K.; Gottschaldt, J.; Schulze, F.; Werner, E.; Erler, W.; Borrmann, E. 2002: The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines Deutsche Tierärztliche Wochenschrift 109(4): 178-182
Strobl, W. 2001: Botulinum toxin type a in the treatment plan for cerebral palsy Wiener Klinische Wochenschrift 113(Suppl 4): 30-35
Lee, S-Keun.; Jun, H.Jin. 2018: Esotropia following botulinum toxin type A injection for facial wrinkles Journal of Cosmetic and Laser Therapy 20(1): 50-51
Rusciani, L.; Severino, E.; Rusciani, A. 2002: Type a botulinum toxin: a new treatment for axillary and palmar hyperhidrosis Journal of Drugs in Dermatology: Jdd 1(2): 147-151
Cherniavskii, V.I.; Konik, V.I. 1972: Study of the stability of purified concentrated Clostridium botulinum type e anatoxin during the storage process Mikrobiolohichnyi Zhurnal 34(3): 373-374
2013: Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely Prescrire International 22(134): 12-13
Duan, C.; Xu, G.; Zhou, J.; Wei, G.; Li, S. 2011: Effect of botulinum toxin type a on excessive expansion of myocutaneous flap Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 25(9): 1063-1066
Beer, K.; Waibel, J. 2007: Botulinum toxin type a enhances the outcome of fractional resurfacing of the cheek Journal of Drugs in Dermatology: Jdd 6(11): 1151-1152
Günther, O.; Bitterlich, N. 2011: Treatment of myofascial pain syndrome (MPS) with botulinum toxin type a (BoNT-A) MMW Fortschritte der Medizin 153(Suppl 2): 64-69
Rymkiewicz, D.; Sawicki, J.; Brühl, A.; Sochańska, R. 1979: Preparation and evaluation of immunogenic properties of Clostridium perfringens type a toxoid Medycyna Doswiadczalna i Mikrobiologia 31(2): 95-102
Monheit, G.; Lin, X.; Nelson, D.; Kane, M. 2012: Consideration of muscle mass in glabellar line treatment with botulinum toxin type a Journal of Drugs in Dermatology: Jdd 11(9): 1041-1045
Glaser, D.A. 2004: Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type a Journal of Drugs in Dermatology: Jdd 3(6): 627-631
Vo, A.H.; Satori, R.; Jabbari, B.; Green, J.; Killgore, W.D.S.; Labutta, R.; Campbell, W.W. 2007: Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial Aviation Space and Environmental Medicine 78(5 Suppl): B113-B118